Related Experiment Video
Updated: Apr 30, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Relationship between left atrial/left ventricular diameter ratio and outcomes in patients with hypertrophic
Keigo Kanbayashi1, Yuichiro Minami1, Shintaro Haruki1
1Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
Insights
The left atrial to left ventricular diameter ratio can predict hypertrophic cardiomyopathy (HCM) death risk. A higher ratio indicates a greater likelihood of HCM-related mortality, aiding in patient risk stratification.
Area of Science:
- Cardiology
- Echocardiography
- Cardiovascular Disease
Background:
- Diastolic dysfunction is central to hypertrophic cardiomyopathy (HCM) pathophysiology.
- The prognostic value of diastolic function parameters in HCM requires clarification.
- Severe diastolic dysfunction in HCM often presents with left atrial (LA) dilation and a disproportionately small left ventricle (LV).
Purpose of the Study:
- To investigate the relationship between the LA/LV diameter ratio and outcomes in patients with HCM.
- To assess the LA/LV diameter ratio as a potential indicator of HCM disease progression and mortality.
Main Methods:
- Echocardiographic evaluation of LA and LV end-diastolic diameters in 468 HCM patients.
- Classification of patients into two groups based on LA/LV diameter ratio: >1 and ≤1.
- Comparison of HCM-related death rates between the two groups.
Main Results:
- A higher LA/LV diameter ratio (>1) was observed in 20.5% of patients.
- Univariate analysis showed a significantly higher likelihood of HCM-related death in patients with an LA/LV ratio >1 (log-rank p=0.002).
- Multivariate analysis identified an LA/LV diameter ratio >1 as an independent determinant of HCM-related death (adjusted hazard ratio: 1.87, p=0.024).
Conclusions:
- The LA/LV diameter ratio is an easily measurable parameter.
- This ratio may serve as a valuable tool for risk stratification of HCM-related death.
- Utilizing the LA/LV diameter ratio can aid clinicians in identifying high-risk HCM patients.
Background:
Although diastolic dysfunction is the main pathophysiological feature of hypertrophic cardiomyopathy (HCM), it remains to be clarified whether parameters of diastolic function can reliably determine HCM prognosis. In patients with reduced left ventricular (LV) distensibility, chronic elevation of LV diastolic pressure is seen with a smaller than expected LV size. Accordingly, patients with HCM with severe LV diastolic dysfunction typically demonstrate left atrial (LA) dilation and a disproportionately smaller left ventricle. Therefore, we investigated the relationship between LA/LV diameter ratio, as a potential indicator of disease progression, and outcomes in patients with HCM.
Methods:
We included 468 patients in whom LA and LV end-diastolic diameter were successfully evaluated by echocardiography at the initial assessment. We divided the patients into two groups: those with an LA/LV diameter ratio > 1 and those with an LA/LV diameter ratio ≤ 1. We compared the HCM-related death rates between the two groups.
Results:
Of the 468 patients, 96 patients (20.5 %) with HCM showed an LA/LV diameter ratio > 1. In the univariate analysis, patients with an LA/LV diameter ratio > 1 had a significantly greater likelihood of HCM-related death than patients with an LA/LV diameter ratio ≤ 1 (log-rank p = 0.002). In the multivariate Cox proportional hazards analysis, when including LA/LV diameter ratio > 1 and imbalanced baseline variables, an LA/LV diameter ratio > 1 was an independent determinant of HCM-related death (adjusted hazard ratio: 1.87, 95 % confidence interval: 1.08-3.24; p = 0.024).
Conclusion:
LA/LV diameter ratio can be easily evaluated and may be useful for risk stratification of HCM-related death in patients with HCM.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

